Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for VECURONIUM BROMIDE

  • FDA Approval
  • Dec. 11, 2025, 09:44 UTC
  • 41
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: VECURONIUM BROMIDE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for REZZAYO

  • FDA Approval
  • Dec. 11, 2025, 09:44 UTC
  • 35
  • 0 comments

Labeling changes approved for MUNDIPHARMA. Active ingredient: REZAFUNGIN ACETATE. Decision date: 12/10/2025

Comment Full text

FDA updates labeling for THALLOUS CHLORIDE TL 201

  • FDA Approval
  • Dec. 11, 2025, 09:44 UTC
  • 33
  • 0 comments

Labeling changes approved for CURIUM. Active ingredient: THALLOUS CHLORIDE TL-201. Decision date: 12/10/2025

Comment Full text

FDA updates labeling for MOMETASONE FUROATE

  • FDA Approval
  • Dec. 11, 2025, 09:44 UTC
  • 31
  • 0 comments

Labeling changes approved for FOUGERA PHARMS. Active ingredient: MOMETASONE FUROATE. Decision date: 12/10/2025

Comment Full text

FDA updates labeling for IMITREX

  • FDA Approval
  • Dec. 10, 2025, 19:50 UTC
  • 38
  • 0 comments

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN SUCCINATE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for IMITREX

  • FDA Approval
  • Dec. 10, 2025, 19:50 UTC
  • 34
  • 0 comments

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN SUCCINATE. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for IMITREX

  • FDA Approval
  • Dec. 10, 2025, 19:50 UTC
  • 32
  • 0 comments

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN. Decision date: 12/09/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 10, 2025, 09:37 UTC
  • 43
  • 0 comments

Labeling changes approved for HIBROW HLTHCARE. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/05/2025

Comment Full text

FDA expands indications for RECARBRIO

  • FDA Approval
  • Dec. 10, 2025, 09:37 UTC
  • 40
  • 0 comments

MSD MERCK CO receives approval for new indications. Submission: SUPPL-8. Decision date: 12/09/2025

Comment Full text

FDA regulatory update for RYSTIGGO

  • FDA Approval
  • Dec. 10, 2025, 09:37 UTC
  • 42
  • 0 comments

Administrative update #SUPPL-7 for UCB INC. Status: Approval. Decision date: 12/09/2025

Comment Full text
  • Previous
  • 51
  • 52
  • 53
  • 54
  • 55
  • Next

Search

News categories

  • Technical Exchange News(11280)
  • Event(2616)
  • SEC News(198606)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131909)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin